<unk>  is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It is also the active ingredient of<unk> /timolol along with timolol maleate. A 2017 Cochrane review found insufficient evidence to determine if<unk>  slows optic nerve damage. In 2013, the FDA approved topical application of<unk>  0.33% gel for persistent facial redness of rosacea.
Brimonidine
Clonidine
Metergoline
Phenylephrine
Acebutolol
Avacopan
Cabergoline
Drospirenone